In its year end trading update, Totally has warned that while revenues for the year ending March 2023 are expected to be broadly in line with expectations, EBITDA will fall
short of forecasts while still being marginally higher than FY22. The Board cites workforce shortages, inflation and increased usage of agency staff as factors inflating
the cost base, all of which are similarly impacting the NHS itself. The Group and management team are nevertheless resilient and we anticipate a continuation ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Totally Update
Totally Plc (TLY:LON) | 4.6 0 0.0% | Mkt Cap: 9.04m
- Published:
02 Mar 2023 -
Author:
Ian Jermin -
Pages:
2
In its year end trading update, Totally has warned that while revenues for the year ending March 2023 are expected to be broadly in line with expectations, EBITDA will fall
short of forecasts while still being marginally higher than FY22. The Board cites workforce shortages, inflation and increased usage of agency staff as factors inflating
the cost base, all of which are similarly impacting the NHS itself. The Group and management team are nevertheless resilient and we anticipate a continuation ....